Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease

Bone Marrow Transplantation

Volumn 20, Issue 3, 1997, Pages 227-234

  Liem, L M ^a   Koelman, C A ^a   Doxiadis, I I N ^a   Van Houwelingen, J C ^a   Goulmy, E ^a   Claas, F H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone marrow transplantation; Graft versus host disease; sHLA class I

Indexed keywords

BILIRUBIN; HLA ANTIGEN CLASS 1;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION; LIVER; MALE; MEASUREMENT; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY;

EID: 0030816806     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700877     Document Type: Article

References (30)

1. Beatty PG, Hansen JA, Lonton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991; 51: 443-447.
2. Van Rood JJ, van Leeuwen A, van Santen MCT. Anti-HLA-A2 inhibitor in normal serum. Nature 1970; 226: 366-367.
3. Charlton RK, Zmijewski CM. Soluble HLA-A7 antigen: Localization in the β-lipoprotein fraction of human serum. Science 1970; 170: 636-637.
4. Singh PB, Brown RE, Roser B. Class I transplantation antigens in solution in body fluids and in the urine. Individuality signals to the environment. J Exp Med 1988; 168: 195-211.
5. Krangel MS. Two forms of HLA class I molecules in human plasma. Hum Immunol 1987; 20: 155-165.
6. Kao KJ. Plasma and platelet HLA in normal individuals: quantitation by competitive enzyme-linked immunoassay. Blood 1987; 70: 282-286.
7. Kao KJ, Scornik JC, Riley WJ, McQueen CF. Association between HLA phenotype and HLA concentration in plasma or platelets. Hum Immunol 1988; 21: 115-124.
8. Doxiadis I, Westhoff U, Grosse-Wilde H. Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut 1989; 59: 449-454.
9. Ferrone S, Yamamura M, Grosse-Wilde H, Pouletty P. Summary of the serum soluble HLA class Iantigen component. In: Tsuji K, Aizawa M, Sasazuki T (eds). Proceedings 11th International Histocompatibility Workshop. Oxford Science Publications: New York; 1992; pp 1057-1061.
10. Alvarez-Cemeño JC, Echevarra JM, Villar LM et al. Soluble class I antigens in serum and CSF of patients with Varicella-Zoster virus meningitis. J Neural Neurosurg Psychiatry 1989; 52: 1194-1196.
11. Puppo F, Brenci S, Lanza L et al. Increased level of serum class I antigens in HIV infection. Correlation with disease progression. Hum Immunol 1994; 40: 259-266.
12. Saririan K, Attiyeh E, Contini P, Russo C. sHLA-I class I levels in elderly human following influenza vaccination. Hum Immunol 1993; 37: 129.
13. Davies HffS, Pollard SG, Caine RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989; 47: 524-527.
14. Puppo F, Pellicci R, Brenci S et al. HLA class-I soluble antigen serum levels in liver transplantation. A predictor marker of acute rejection. Hum Immunol 1994; 40: 166-170.
15. DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor specific, soluble HLA class I. Hum Immunol 1994; 40: 191-201.
16. Zavazava N, Böttcher H, Müller Ruchholtz W. Soluble MHC class I antigens (sHLA-I) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 1993; 42: 20-26.
17. Claas F, Jankowska-Gan E, DeVito LD et al. Monitoring of heart transplant rejection using a donor-specific soluble class I ELISA. Hum Immunol 1993; 37: 121.
18. Schroeder TJ, Pouletty P, Shimizu RM et al. Soluble class I HLA antigens in serum following renal transplantation. Hum Immunol 1993; 37: 130.
19. Drouet M, Petit B, Peyronnet P et al. Soluble HLA class I antigens in kidney allograft recipients. Transplant Proc 1995; 27: 1671.
20. Tsuji K, Kusama M, Nakatsuji T, Kato S. Biological significance of Ss (serum soluble) HLA-class I antigens in bone marrow transplantation. Tokai J Exp Clin Med 1985; 10: 169-174.
21. Westhoff U, Doxiadis I, Beelen DW et al. Soluble HLA class I concentrations and GVHD after allogeneic marrow transplantation. Transplantation 1989; 48: 891-893.
22. Puppo F, Brenci S, Ghio M et al. Serum HLA class I levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD. Bone Marrow Transplant 1996; 17: 735-738.
23. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 292: 832-843.
24. Auzlitzky WE, Grosse-Wilde H, Westhoff U et al. Enhanced serum levels of soluble class I molecules are induced by treatment with recombinant interferon-gamma. Clin Exp Immunol 1991; 86: 236-239.
25. Hillebrand K, Moritz T, Westhoff U et al. HLA class I and beta-2-microglobulin plasma concentrations during interferon treatment of chronic myelogenous leukemia. Vox Sang 1994; 67: 310-314.
26. Ferrara JLM. Cytokine dysregulation as a mechanism of graft-versus-host-disease. Curr Opin Immunol 1993; 5: 794-799.
27. Hausmann R, Zavazava N, Müller-Rochholtz W. Interaction of purified HLA class I molecules with alloreactive CTL. Transplant Proc 1991; 23: 2255-2257.
28. Buelow R, Burlingham WJ, Clayberger C. Immunomodulation by soluble HLA class I. Transplantation 1995; 59: 649-654.
29. Carbone E, Terrazzano G, Colonna M et al. Natural killer clones recognize specific soluble HLA class I molecules. Eur J Immunol 1996; 26: 683-689.
30. Zavazava N, Krönke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 1996; 2: 1005-1010.